Variant report
Variant | nsv511901 |
---|---|
Chromosome Location | chr6:78426393-78436096 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs559774566 | chr6:78426395-78426396 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs576544818 | chr6:78426465-78426466 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs191240205 | chr6:78426498-78426499 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs545564041 | chr6:78426513-78426514 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs146332448 | chr6:78426530-78426531 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs182747132 | chr6:78426535-78426536 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs536595085 | chr6:78426591-78426592 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs531620226 | chr6:78426593-78426594 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs138269142 | chr6:78426663-78426664 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs369050462 | chr6:78426690-78426691 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs371305781 | chr6:78426691-78426692 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs111704480 | chr6:78426746-78426747 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs13219568 | chr6:78426776-78426777 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs6940113 | chr6:78426796-78426797 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs570926277 | chr6:78426797-78426798 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs375702572 | chr6:78436004-78436005 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs190216382 | chr6:78436018-78436019 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs558041422 | chr6:78436033-78436034 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs557239599 | chr6:78436035-78436036 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs540141878 | chr6:78436040-78436041 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs150926187 | chr6:78436055-78436056 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs574033398 | chr6:78436064-78436065 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
Breast cancer | 17133270 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Developmental delay | 21147756 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Lung cancer | 16773561 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Prostate cancer | 16461572 | CNVD |
Mental retardation | 21045960 | CNVD |
Obesity | 21045960 | CNVD |
learning difficulties | 21045960 | CNVD |
Prostate cancer | 17245344 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:78425600-78426600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
2 | chr6:78425800-78426400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr6:78425800-78426400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
4 | chr6:78425800-78426400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
5 | chr6:78425800-78426800 | Enhancers | H9 Cell Line | embryonic stem cell |
6 | chr6:78425800-78426800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
7 | chr6:78425800-78426800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
8 | chr6:78426000-78426600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
9 | chr6:78426000-78426800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
10 | chr6:78426200-78426600 | Flanking Active TSS | ES-I3 Cell Line | embryonic stem cell |
11 | chr6:78436000-78436400 | Enhancers | H9 Cell Line | embryonic stem cell |
12 | chr6:78436000-78436600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr6:78436000-78436600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
14 | chr6:78436000-78436600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |